Lesson 2 — Why Should I Care?

Understanding the Complex: How Do Vaccines Actually Work?

---

In 1967, the World Health Organization launched what many historians of medicine consider the most successful public health campaign in human history. Their goal: eradicate smallpox entirely from the face of the earth.

Smallpox had killed more people than any other disease in recorded history — an estimated 300 to 500 million people in the twentieth century alone. It had toppled empires, ended indigenous civilizations in the Americas, and disfigured generations of survivors. Pharaoh Ramesses V, who died in 1157 BCE, may have had it; the scarring visible on his mummified face suggests as much.

In 1980 — thirteen years after the WHO campaign began — the world declared smallpox eradicated. Not controlled. Not reduced. Gone. The last naturally occurring case was in Somalia in 1977. It remains the only human infectious disease ever to have been completely eliminated from nature.

The weapon that did it was a vaccine.

---

Not every disease can be eradicated that way — smallpox had properties that made it uniquely vulnerable. But the point is not the exception; it is what the exception reveals about what vaccines can do at scale.

Here are three reasons this matters right now:

The COVID moment. The COVID-19 pandemic killed an estimated 15 to 20 million people in its first two years, by excess mortality calculations — the actual death toll is substantially higher than official counts. Vaccines, once widely deployed, reduced severe disease, hospitalizations, and deaths dramatically. The Oxford-AstraZeneca and BioNTech-Pfizer vaccines were estimated to have prevented over a million deaths in the UK alone in their first year. That is not a speculation — it is a modeled estimate based on hospitalization data, but the orders of magnitude are not seriously disputed. The speed of development was extraordinary. Understanding how it was possible tells you something fundamental about where medicine is going.

Antibiotic resistance and the next pandemic. The world has used antibiotics so heavily — in humans and in livestock — that bacteria are evolving resistance faster than we can develop new drugs. Some strains of tuberculosis are now nearly untreatable. Vaccine-preventable diseases that were once declining are returning as vaccination rates drop. This is not a hypothetical threat; it is happening. The question of how quickly we can develop and deploy vaccines for new pathogens will determine, in part, how the next pandemic unfolds. COVID gave us a preview — both of the disaster and of the response.

mRNA cancer vaccines. This is perhaps the least-reported development in medicine in the last five years. The same mRNA technology that produced the COVID vaccines within months is now being used to build personalized cancer vaccines — vaccines tailored to the specific mutations of an individual patient's tumor. A Phase 2 trial by Moderna and MSD (Merck) published in 2022 showed a ~44% reduction in recurrence or death in melanoma patients who received an mRNA cancer vaccine alongside standard immunotherapy. This is early data, and Phase 3 results are pending. But if this approach works — and the early signals are genuinely encouraging — it will be one of the most consequential developments in oncology in decades.

---

None of this is simple, and none of it is settled. There are real debates about vaccine authorization speed, equitable access, and mandatory vaccination. Those debates matter, and this course will engage with them honestly — without telling you what to conclude.

But to understand any of it, you need to understand what a vaccine actually does to the cells of your body. That starts with the immune system.

---

Next lesson: The background you need — what viruses are, what proteins do, and why the immune system needs to "learn."

---

Reading time: approx. 8–9 minutes